Devicelab Signs Partnership Agreement With Microchip Technology

DeviceLab Signs Partnership Agreement with Microchip Technology

Reinforces DeviceLab’s Proficiency in Electronic Medical Product Design

TUSTIN, Calif., Feb. 8—DeviceLab Inc., an Orange County medical product design and product development company, today announced that it has signed a partnership agreement with Microchip Technology Inc. (NASDAQ:MHCP).

DeviceLab logo The five-year agreement enables Microchip customers to more readily seek and engage DeviceLab’s highly qualified support for the design of medical products and equipment that use PIC® microcontrollers (and dsPIC® digital signal controllers.


Microchip’s world-class development tools provide powerful, affordable solutions for application development. Compilers, assemblers, programmers, simulators, and in-circuit emulators are available components of Microchip’s MPLAB® Integrated Development Environment (IDE).

“Microchip’s products and experience have helped hundreds of the world’s top medical device companies take their ideas from future vision to market reality, and it is our privilege to continue to be part of that tradition,” said DeviceLab founder and CEO Dac Vu.

Vu said that DeviceLab has collaborated on nearly a dozen electronic medical product design projects with Microchip in recent years. Further, he said that his technical staff’s proven depth of knowledge of Microchip’s products helped facilitate the partnership agreement.

“Nearly all DeviceLab projects include electronic systems design and software development,” said Vu. “Having a relationship with such a recognized leader in microprocessor manufacturing positions us to continue to demonstrate the true capabilities of our extensive team—which includes electrical and electronic engineers, systems engineers and software programmers—and to maximize the potential of Microchip’s products.”